Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hill expands ephedra investigation

This article was originally published in The Tan Sheet

Executive Summary

Former Yellow Jackets manufacturer NVE Pharmaceuticals is latest firm to receive House Energy & Commerce Committee letter as part of its ongoing ephedra investigation. Correspondence, sent April 21, asks NVE President Robert Occhifinto to disclose information on its marketing practices and AEs related to sale of Yellow Jackets. Committee also recently expanded its inquiry to include PediaLean children's weight-loss supplement (1"The Tan Sheet" April 14, 2003, p. 4). Yellow Jackets and NVE were the subject of an FDA investigation and concurrent Senate subcommittee hearing in October 2002 (2"The Tan Sheet" Oct. 14, 2002, p. 6). Firm has until May 5 to respond...

You may also be interested in...



Steroid Precursor Legislative Action Gains Momentum

"Pro-steroid" and "precursor steroid" products' proliferation in the dietary supplement market "raise[s] questions about whether additional federal action should be taken," according to the House Energy & Commerce Committee

NVE Pharmaceuticals N.J. Plant Stung In FDA Yellow Jacket Investigation

FDA is in the process of inspecting NVE Pharmaceuticals' Newton, N.J. plant, where Yellow Jacket ephedra/caffeine supplements are manufactured

Medtech Biggest Casualty In Swiss/EU Uncertainty As Worst Case Scenario Looms

Eighteen years of free trade threatens to crash, as a result of the stalemate in the market access agreement between Switzerland and the EU. Industry association Swiss Medtech is advising local medtech manufacturers to find notified bodies and authorized representatives based in the EU. However, local company SQS remains confident of its ongoing notified body role.

Topics

UsernamePublicRestriction

Register

PS095396

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel